Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depot Octreotide for Prevention of Diarrhea in Pelvic Radiation
NCT00033605Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Apr 2002
- Primary completion
- Jul 2006
- Modality
- Peptides
01
Overview
Phase 3, randomised, double-blind trial in radiation enteritis comparing Octreotide + Radiation with Placebo + Radiation (2 arms). Primary endpoint: Reduction of diarrhea as measured by NCI CTC version 2.0 up to 2 years. Started Apr 2002; status: completed.
02
Drugs
octreotide
03
Conditions
radiation enteritis
Beyond the preview
Go deeper on NCT00033605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033605.